Pay in 4 interest-free payments of $6.49 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
companies making glp-1 drugs isn't something a drug company invented. It's a hormone your body has been every single day of your life. This isn't an anti-Ozempic post. These medications have changed lives, but Novo Nordisk Drops Hims Purchase Type:One Time force-sold-out
Novo Nordisk Drops Hims & Hers: Inside the Compounded GLP-1 Crisis | Pharmacy Times
These medications (including semaglutide, dulaglutide, and liraglutide) are typically considered when: Metformin and other oral medications have not achieved adequate glycaemic control The patient has a BMI ≥35 kg/m² (or lower thresholds, typically by around 2.5 kg/m², for people of certain ethnic backgrounds including South Asian) Weight loss would benefit other obesity-related comorbidities Insulin therapy is being considered but would have significant occupational implications or weight gain is a concern Continuation criteria apply: for example, treatment should reduce HbA1c by at least 11 mmol/mol (1.0%) and weight by at least 3% at 6 months to be continued
force-sold-out
Purchase Type:One Time
This leads to reduced calorie intake and supports sustainable weight loss
US$ 22.72
US$ 24.82
US$ 29.63
US$ 28.40
US$ 26.75
US$ 28.39